Mauro D'Amato

Dr. Mauro D'Amato

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2012 in Nature
Verified
Journal Article
Open access
PDF file
T(The International IBD Genetics Consortium (IIBDGC)
The International IBD Genetics Consortium (IIBDGC)
LJLuke Jostins
Luke Jostins
SRStephan Ripke
Stephan Ripke
RWRinse K. Weersma
Rinse K. Weersma
RDRichard H. Duerr
Richard H. Duerr
JCJudy H Cho
Judy H Cho
A meta-analysis of previous genome-wide association studies of Crohn’s disease and ulcerative colitis, the two most common forms of inflammatory bowel disease, with a combined total of more than 75,000 cases and controls, finds that most loci contribute to both phenotypes and other immune-mediated disorders. Genetic studies have implicated unsuspected mechanisms in the pathogenesis of Crohn's disease and ulcerative colitis, two of the most common forms of inflammatory bowel disease. This paper presents a meta-analysis of published genome-wide association studies, together with validation in more than 75,000 cases and controls. In addition to several new associations, the authors find that most loci contribute to both phenotypes, but also to other immune-mediated disorders. The data reveal an overlap between susceptibility loci for inflammatory bowel disease and mycobacterial infection, and between the pathways that govern host responses to mycobacteria and those predisposing to inflammatory bowel disease. Crohn’s disease and ulcerative colitis, the two common forms of inflammatory bowel disease (IBD), affect over 2.5 million people of European ancestry, with rising prevalence in other populations1. Genome-wide association studies and subsequent meta-analyses of these two diseases2,3 as separate phenotypes have implicated previously unsuspected mechanisms, such as autophagy4, in their pathogenesis and showed that some IBD loci are shared with other inflammatory diseases5. Here we expand on the knowledge of relevant pathways by undertaking a meta-analysis of Crohn’s disease and ulcerative colitis genome-wide association scans, followed by extensive validation of significant findings, with a combined total of more than 75,000 cases and controls. We identify 71 new associations, for a total of 163 IBD loci, that meet genome-wide significance thresholds. Most loci contribute to both phenotypes, and both directional (consistently favouring one allele over the course of human history) and balancing (favouring the retention of both alleles within populations) selection effects are evident. Many IBD loci are also implicated in other immune-mediated disorders, most notably with ankylosing spondylitis and psoriasis. We also observe considerable overlap between susceptibility loci for IBD and mycobacterial infection. Gene co-expression network analysis emphasizes this relationship, with pathways shared between host responses to mycobacteria and those predisposing to IBD.

21 November 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AFAndre Franke
Andre Franke
DMDermot P B McGovern
Dermot P B McGovern
JBJeffrey C Barrett
Jeffrey C Barrett
KWKai Wang
Kai Wang
GRGraham L Radford-Smith
Graham L Radford-Smith
MPMiles Parkes
Miles Parkes

18 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AKAlexander Kurilshikov
Alexander Kurilshikov
CGCarolina Medina Gomez
Carolina Medina Gomez
RBRodrigo Bacigalupe
Rodrigo Bacigalupe
DRDjawad Radjabzadeh
Djawad Radjabzadeh
JWJun Wang
Jun Wang
AZAlexandra Zhernakova
Alexandra Zhernakova

6 February 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CACarl A Anderson
Carl A Anderson
GBGabrielle Boucher
Gabrielle Boucher
CLCharlie W Lees
Charlie W Lees
AFAndre Franke
Andre Franke
MDMauro D'Amato
Mauro D'Amato
JRJohn D Rioux
John D Rioux
John Rioux and colleagues report results of a large genome-wide association meta-analysis and follow-up study of ulcerative colitis. They identify 29 new risk loci for this inflammatory disease and show that many risk loci are shared between ulcerative colitis and Crohn's disease. Genome-wide association studies and candidate gene studies in ulcerative colitis have identified 18 susceptibility loci. We conducted a meta-analysis of six ulcerative colitis genome-wide association study datasets, comprising 6,687 cases and 19,718 controls, and followed up the top association signals in 9,628 cases and 12,917 controls. We identified 29 additional risk loci (P < 5 × 10−8), increasing the number of ulcerative colitis–associated loci to 47. After annotating associated regions using GRAIL, expression quantitative trait loci data and correlations with non-synonymous SNPs, we identified many candidate genes that provide potentially important insights into disease pathogenesis, including IL1R2, IL8RA-IL8RB, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1. The total number of confirmed inflammatory bowel disease risk loci is now 99, including a minimum of 28 shared association signals between Crohn's disease and ulcerative colitis.

13 February 2017 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
JHJonas Halfvarson
Jonas Halfvarson
CBColin J. Brislawn
Colin J. Brislawn
RLRegina Lamendella
Regina Lamendella
YVYoshiki Vázquez-Baeza
Yoshiki Vázquez-Baeza
WWWilliam A. Walters
William A. Walters
JJJanet K. Jansson
Janet K. Jansson
Inflammatory bowel disease (IBD) is characterized by flares of inflammation with a periodic need for increased medication and sometimes even surgery. The aetiology of IBD is partly attributed to a deregulated immune response to gut microbiome dysbiosis. Cross-sectional studies have revealed microbial signatures for different IBD subtypes, including ulcerative colitis, colonic Crohn's disease and ileal Crohn's disease. Although IBD is dynamic, microbiome studies have primarily focused on single time points or a few individuals. Here, we dissect the long-term dynamic behaviour of the gut microbiome in IBD and differentiate this from normal variation. Microbiomes of IBD subjects fluctuate more than those of healthy individuals, based on deviation from a newly defined healthy plane (HP). Ileal Crohn's disease subjects deviated most from the HP, especially subjects with surgical resection. Intriguingly, the microbiomes of some IBD subjects periodically visited the HP then deviated away from it. Inflammation was not directly correlated with distance to the healthy plane, but there was some correlation between observed dramatic fluctuations in the gut microbiome and intensified medication due to a flare of the disease. These results will help guide therapies that will redirect the gut microbiome towards a healthy state and maintain remission in IBD.

14 March 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
T(The International IBD Genetics Consortium (IIBDGC)
The International IBD Genetics Consortium (IIBDGC)
DEDavid Ellinghaus
David Ellinghaus
I(International Genetics of Ankylosing Spondylitis Consortium (IGAS)
International Genetics of Ankylosing Spondylitis Consortium (IGAS)
I(International PSC Study Group (IPSCSG)
International PSC Study Group (IPSCSG)
G(Genetic Analysis of Psoriasis Consortium (GAPC)
Genetic Analysis of Psoriasis Consortium (GAPC)
AFAndre Franke
Andre Franke
David Ellinghaus and colleagues report a combined association analysis of five chronic inflammatory diseases. They identify 27 new associations and highlight disease-specific association patterns at shared susceptibility loci. We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.